Enrofloxacin 20 g, long acting vehicle q.s.ad. 100 mL
Enroflox® 20 L.A.
Injectable Solution
Thrid-generation quinolone in long-acting vehicle
Formulation
Indications
For the treatment of infectious diseases caused by Gram-positive, Gram-negative bacteria and mycoplasma susceptible to enrofloxacine, basicaly of the respiratory tract, urinary, digestive tract, auditive conduct and skin. Bovine respiratory disease, colibacilosis, salmonellosis, neumonia, bronconeumonia, mycoplasmosis, dermatitis, mastitis-metritis-agalactia, rhinitis among others. Its vehicle provides 72 hours action.
Dosage and Administration
Cattle, sheep, goats, camelids amd swines: 1 mL/40-80 Kg, dogs and cats: 0.1 mL/4 Kg, subcutanoeus or intramuscular route; poultry : 0.15 mL/2 Kg intramuscular route.
Commercial Presentation
Bottle x 100 mL , Bottle x 250 mL ,
registro SAGARPA
México Registro SAGARPA Q-0616-019
MORE VISITED PRODUCTS
